These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 2233904

  • 1. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J, Käyhty H, Takala AK, Peltola H, Rönnberg PR, Kela E, Pekkanen E, McVerry PH, Mäkelä PH.
    N Engl J Med; 1990 Nov 15; 323(20):1381-7. PubMed ID: 2233904
    [Abstract] [Full Text] [Related]

  • 2. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B, Wald E, Guerra N, Byers C.
    Pediatrics; 1990 Apr 15; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
    Eskola J, Peltola H, Takala AK, Käyhty H, Hakulinen M, Karanko V, Kela E, Rekola P, Rönnberg PR, Samuelson JS.
    N Engl J Med; 1987 Sep 17; 317(12):717-22. PubMed ID: 3306379
    [Abstract] [Full Text] [Related]

  • 4. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
    Santosham M, Wolff M, Reid R, Hohenboken M, Bateman M, Goepp J, Cortese M, Sack D, Hill J, Newcomer W.
    N Engl J Med; 1991 Jun 20; 324(25):1767-72. PubMed ID: 1903846
    [Abstract] [Full Text] [Related]

  • 5. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R, Arditi M, Chadwick EG, Amer MD, Sroka PA.
    Pediatrics; 1990 Apr 20; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
    Miller MA, Meschievitz CK, Ballanco GA, Daum RS.
    Pediatrics; 1995 Apr 20; 95(4):522-7. PubMed ID: 7700752
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen.
    Bewley KM, Schwab JG, Ballanco GA, Daum RS.
    Pediatrics; 1996 Nov 20; 98(5):898-904. PubMed ID: 8909483
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
    Peltola H, Käyhty H, Sivonen A, Mäkelä H.
    Pediatrics; 1977 Nov 20; 60(5):730-7. PubMed ID: 335348
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age.
    Käyhty H, Peltola H, Eskola J, Rönnberg PR, Kela E, Karanko V, Mäkelä PH.
    Pediatrics; 1989 Dec 20; 84(6):995-9. PubMed ID: 2587155
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
    Berkowitz CD, Ward JI, Chiu CE, Marcy SM, Gordon L, Hendley JO, Meier K, Marchant CD, McVerry P.
    Pediatrics; 1990 Mar 20; 85(3):288-93. PubMed ID: 2304781
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Kaiser-UCLA Vaccine Study Group.
    Vadheim CM, Greenberg DP, Partridge S, Jing J, Ward JI.
    Pediatrics; 1993 Aug 20; 92(2):272-9. PubMed ID: 8337029
    [Abstract] [Full Text] [Related]

  • 19. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
    Kurikka S, Käyhty H, Peltola H, Saarinen L, Eskola J, Mäkelä PH.
    Pediatrics; 1995 Jun 20; 95(6):815-22. PubMed ID: 7761204
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.